• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呋塞米自微乳释液体胶囊剂的处方前研究与体外评价。

Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide.

机构信息

Faculty of Pharmacy, Damascus University, Damascus, Syria.

Faculty of Pharmacy, Arab International University, P.O. Box 16180, Ghabaghib, Daraa, Syria.

出版信息

Sci Rep. 2021 Jan 14;11(1):1315. doi: 10.1038/s41598-020-79940-5.

DOI:10.1038/s41598-020-79940-5
PMID:33446749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7809212/
Abstract

Self-nanoemulsifying drug delivery systems (SNEDDS) were used to enhance the dissolution rate of furosemide as a model for class IV drugs and the system was solidified into liquisolid tablets. SNEDDS of furosemide contained 10% Castor oil, 60% Cremophor EL, and 30% PEG 400. The mean droplets size was 17.9 ± 4.5 nm. The theoretical model was used to calculate the amounts of the carrier (Avicel PH101) and coating materials (Aerosil 200) to prepare liquisolid powder. Carrier/coating materials ratio of 5/1 was used and Ludipress was added to the solid system, thus tablets with hardness of 45 ± 2 N were obtained. Liquisolid tablets showed 2-folds increase in drug release as compared to the generic tablets after 60 min in HCl 0.1 N using USP apparatus-II. Furosemide loaded SNEDDS tablets have great prospects for further in vivo studies, and the theoretical model is useful for calculating the adequate amounts of adsorbents required to solidify these systems.

摘要

自微乳药物传递系统 (SNEDDS) 被用于提高呋塞米的溶解速率,将其作为 IV 类药物的模型,并且该系统被固化为液固片剂。呋塞米的 SNEDDS 包含 10%的蓖麻油、60%的 Cremophor EL 和 30%的 PEG 400。平均液滴大小为 17.9±4.5nm。使用理论模型来计算载体(Avicel PH101)和包衣材料(Aerosil 200)的量,以制备液固粉末。使用 5/1 的载体/包衣材料比,并向固体系统中添加 Ludipress,从而获得硬度为 45±2N 的片剂。与普通片剂相比,在使用 USP 仪器-II 的 0.1N HCl 中 60 分钟后,液固片剂的药物释放增加了 2 倍。载有呋塞米的 SNEDDS 片剂具有进一步进行体内研究的广阔前景,并且该理论模型可用于计算固化这些系统所需的吸附剂的适当用量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/23a1de1cfa8e/41598_2020_79940_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/f94691ddc152/41598_2020_79940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/b792814c6a42/41598_2020_79940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/3c93251e0333/41598_2020_79940_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/9094b3d9ab84/41598_2020_79940_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/43f0ba52f3c8/41598_2020_79940_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/6ee3f6274139/41598_2020_79940_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/23a1de1cfa8e/41598_2020_79940_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/f94691ddc152/41598_2020_79940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/b792814c6a42/41598_2020_79940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/3c93251e0333/41598_2020_79940_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/9094b3d9ab84/41598_2020_79940_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/43f0ba52f3c8/41598_2020_79940_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/6ee3f6274139/41598_2020_79940_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d58/7809212/23a1de1cfa8e/41598_2020_79940_Fig7_HTML.jpg

相似文献

1
Formulation and in vitro evaluation of self-nanoemulsifying liquisolid tablets of furosemide.呋塞米自微乳释液体胶囊剂的处方前研究与体外评价。
Sci Rep. 2021 Jan 14;11(1):1315. doi: 10.1038/s41598-020-79940-5.
2
Incorporating valsartan in sesame oil enriched self-nanoemulsifying system-loaded liquisolid tablets to improve its bioavailability.将缬沙坦纳入芝麻油富化自微乳载液体制剂中以提高其生物利用度。
Int J Pharm. 2023 May 25;639:122966. doi: 10.1016/j.ijpharm.2023.122966. Epub 2023 Apr 20.
3
Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.采用质量源于设计方法通过自纳米乳化片提高厄贝沙坦的口服生物利用度
Drug Deliv. 2014 Sep;21(6):412-35. doi: 10.3109/10717544.2013.853709. Epub 2013 Nov 12.
4
The Development of Self-nanoemulsifying Liquisolid Tablets to Improve the Dissolution of Simvastatin.自微乳释液体片剂的开发以提高辛伐他汀的溶出度。
AAPS PharmSciTech. 2017 Oct;18(7):2586-2597. doi: 10.1208/s12249-017-0743-z. Epub 2017 Feb 24.
5
Effects of liquisolid formulations on dissolution of naproxen.液固体制剂对萘普生溶出度的影响。
Eur J Pharm Biopharm. 2009 Nov;73(3):373-84. doi: 10.1016/j.ejpb.2009.08.002. Epub 2009 Aug 11.
6
Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats.格列美脲自纳米乳化药物传递系统固体分散体片对链脲佐菌素诱导的高血糖大鼠降血糖活性及胰腺组织病理学变化的影响
Nanomaterials (Basel). 2022 Nov 10;12(22):3966. doi: 10.3390/nano12223966.
7
Systematic Development of Self-Nanoemulsifying Liquisolid Tablets to Improve the Dissolution and Oral Bioavailability of an Oily Drug, Vitamin K1.自纳米乳化液体制剂片的系统研发以提高油性药物维生素K1的溶出度和口服生物利用度
Pharmaceutics. 2018 Jul 18;10(3):96. doi: 10.3390/pharmaceutics10030096.
8
Development of novel amisulpride-loaded solid self-nanoemulsifying tablets: preparation and pharmacokinetic evaluation in rabbits.新型阿立哌唑负载型固体自乳化纳米片的研制:家兔体内的制备与药代动力学评价
Drug Dev Ind Pharm. 2017 Sep;43(9):1539-1547. doi: 10.1080/03639045.2017.1322608. Epub 2017 May 11.
9
Development of 3D-Printed, Liquisolid and Directly Compressed Glimepiride Tablets, Loaded with Black Seed Oil Self-Nanoemulsifying Drug Delivery System: In Vitro and In Vivo Characterization.载有黑种草子油自纳米乳化药物递送系统的3D打印、液固压缩和直接压片格列美脲片的研制:体外和体内表征
Pharmaceuticals (Basel). 2022 Jan 5;15(1):68. doi: 10.3390/ph15010068.
10
Liquisolid systems to improve the dissolution of furosemide.改善呋塞米溶出度的液固系统。
Sci Pharm. 2010 Apr-Jun;78(2):325-44. doi: 10.3797/scipharm.0912-23. Epub 2010 Apr 23.

引用本文的文献

1
Enhancing solubility and dissolution of felodipine using self-nanoemulsifying drug systems through in vitro evaluation.通过体外评价,使用自纳米乳化药物系统提高非洛地平的溶解度和溶出度。
Sci Rep. 2025 Mar 14;15(1):8900. doi: 10.1038/s41598-025-90962-9.
2
Adsorbent Precoating by Lyophilization: A Novel Green Solvent Technique to Enhance Cinnarizine Release from Solid Self-Nanoemulsifying Drug Delivery Systems (S-SNEDDS).冻干法吸附剂预包衣:一种增强桂利嗪从固体自纳米乳化药物递送系统(S-SNEDDS)中释放的新型绿色溶剂技术。
Pharmaceutics. 2022 Dec 30;15(1):134. doi: 10.3390/pharmaceutics15010134.
3
Boosting Tadalafil Bioavailability via Sono-Assisted Nano-Emulsion-Based Oral Jellies: Box-Behnken Optimization and Assessment.

本文引用的文献

1
BCS class IV drugs: Highly notorious candidates for formulation development.BCS 分类 IV 药物:制剂开发中极恶名昭彰的候选者。
J Control Release. 2017 Feb 28;248:71-95. doi: 10.1016/j.jconrel.2017.01.014. Epub 2017 Jan 11.
2
Enhanced oral delivery of risperidone through a novel self-nanoemulsifying powder (SNEP) formulations: in-vitro and ex-vivo assessment.通过新型自纳米乳化粉末(SNEP)制剂增强利培酮的口服给药:体外和离体评估
J Microencapsul. 2016 Sep;33(6):544-553. doi: 10.1080/02652048.2016.1223200. Epub 2016 Aug 28.
3
Development of self-nanoemulsifying drug delivery systems for the enhancement of solubility and oral bioavailability of fenofibrate, a poorly water-soluble drug.
通过基于超声辅助纳米乳液的口服凝胶提高他达拉非的生物利用度:Box-Behnken优化与评估
Pharmaceutics. 2022 Nov 24;14(12):2592. doi: 10.3390/pharmaceutics14122592.
4
Influences of Glimepiride Self-Nanoemulsifying Drug Delivery System Loaded Liquisolid Tablets on the Hypoglycemic Activity and Pancreatic Histopathological Changes in Streptozotocin-Induced Hyperglycemic Rats.格列美脲自纳米乳化药物传递系统固体分散体片对链脲佐菌素诱导的高血糖大鼠降血糖活性及胰腺组织病理学变化的影响
Nanomaterials (Basel). 2022 Nov 10;12(22):3966. doi: 10.3390/nano12223966.
5
Tadalafil-Loaded Self-Nanoemulsifying Chewable Tablets for Improved Bioavailability: Design, In Vitro, and In Vivo Testing.用于提高生物利用度的载他达拉非自纳米乳化咀嚼片:设计、体外和体内测试
Pharmaceutics. 2022 Sep 12;14(9):1927. doi: 10.3390/pharmaceutics14091927.
6
Nanocarriers for delivery of siRNA as gene silencing mediator.用于递送作为基因沉默介质的小干扰RNA的纳米载体。
EXCLI J. 2022 Aug 1;21:1028-1052. doi: 10.17179/excli2022-4975. eCollection 2022.
7
Functional Excipients and Novel Drug Delivery Scenario in Self-nanoemulsifying Drug Delivery System: A Critical Note.自纳米乳化药物递送系统中的功能性辅料与新型药物递送方案:一篇评论
Pharm Nanotechnol. 2022 Aug 29. doi: 10.2174/2211738510666220829085745.
8
Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.探讨基于透明质酸的纳米粒子在细菌感染的诊断和治疗中的应用。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 Jul;14(4):e1799. doi: 10.1002/wnan.1799. Epub 2022 Apr 29.
开发自纳米乳化药物递送系统以提高非诺贝特(一种难溶性药物)的溶解度和口服生物利用度。
Int J Nanomedicine. 2016 Jun 14;11:2829-38. doi: 10.2147/IJN.S104187. eCollection 2016.
4
Identification of phases of various oil, surfactant/ co-surfactants and water system by ternary phase diagram.通过三元相图鉴定各种油、表面活性剂/助表面活性剂和水体系的相态。
Acta Pol Pharm. 2014 Mar-Apr;71(2):301-9.
5
Comparative evaluation of various solubility enhancement strategies for furosemide.呋塞米多种溶解度增强策略的比较评估
Pak J Pharm Sci. 2014 Jul;27(4):963-73.
6
Enhanced solubility and oral bioavailability of γ-tocotrienol using a self-emulsifying drug delivery system (SEDDS).使用自乳化药物递送系统(SEDDS)提高γ-生育三烯酚的溶解度和口服生物利用度。
Lipids. 2014 Aug;49(8):819-29. doi: 10.1007/s11745-014-3923-6. Epub 2014 Jun 17.
7
Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation.雷公藤红素固体自微乳化分散片:处方工艺开发、表征及生物利用度评价
Int J Pharm. 2014 Sep 10;472(1-2):40-7. doi: 10.1016/j.ijpharm.2014.06.019. Epub 2014 Jun 11.
8
Self-emulsifying pellets: relations between kinetic parameters of drug release and emulsion reconstitution-influence of formulation variables.自乳化微丸:药物释放动力学参数与乳剂重构之间的关系——制剂变量的影响
J Pharm Sci. 2014 May;103(5):1453-65. doi: 10.1002/jps.23919. Epub 2014 Mar 4.
9
Clinical pharmacology of furosemide in neonates: a review.新生儿呋塞米的临床药理学:综述。
Pharmaceuticals (Basel). 2013 Sep 5;6(9):1094-129. doi: 10.3390/ph6091094.
10
Population-based meta-analysis of furosemide pharmacokinetics.基于人群的呋塞米药代动力学荟萃分析。
Biopharm Drug Dispos. 2014 Mar;35(2):119-33. doi: 10.1002/bdd.1874. Epub 2013 Nov 16.